4
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-22-006332
EVP R&D, Chief Medical Officer sold 2,306 shares at $25.17 ($58,042)
- EVP R&D, Chief Medical Officer gave up 8,527 shares (to pay taxes)
- EVP R&D, Chief Medical Officer acquired 29,008 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2022-02-18 | Sale | −2,306 | $25.17 | $58,042 | 9,496 | D |
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2022-02-20 | Option exercise | +10,096 | 19,592 | D | ||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2022-02-20 | Shares withheld for taxes | −2,966 | $25.08 | $74,387 | 16,626 | D |
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2022-02-21 | Option exercise | +6,875 | 23,501 | D | ||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2022-02-21 | Shares withheld for taxes | −2,022 | $25.08 | $50,712 | 21,479 | D |
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2022-02-22 | Option exercise | +12,037 | 33,516 | D | ||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2022-02-22 | Shares withheld for taxes | −3,539 | $25.01 | $88,510 | 29,977 | D |
| Derivatives | |||||||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2022-02-18 | Grant or award · Employee Stock Option (Right to Buy) | +139,554 | 139,554 | D | ||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2022-02-18 | Grant or award · Restricted Stock Unit Award | +34,889 | 34,889 | D | ||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2022-02-20 | Option exercise · Restricted Stock Unit Award | −10,096 | 20,191 | D | ||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2022-02-21 | Option exercise · Restricted Stock Unit Award | −6,875 | 6,875 | D | ||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2022-02-22 | Option exercise · Restricted Stock Unit Award | −12,037 | 36,114 | D | ||
| Open-market sales · 2,306 sh · avg $25.17 · $58,042 | |||||||
Loading xslF345X03/form4.xml…